Inhibiting KCNMA1-AS1 promotes osteogenic differentiation of HBMSCs via miR-1303/cochlin axis. 2023

Yuan Lin, and Hanhao Dai, and Guoyu Yu, and Chao Song, and Jun Liu, and Jie Xu
Department of Orthopedics, Fujian Provincial Hospital, Fuzhou, China.

OBJECTIVE Osteoporosis is a progressive systemic skeletal disorder. Multiple profiling studies have contributed to characterizing biomarkers and therapeutic targets for osteoporosis. However, due to the limitation of the platform of miRNA sequencing, only a part of miRNA can be sequenced based on one platform. METHODS In this study, we performed miRNA sequencing in osteoporosis bone samples based on a novel platform Illumina Hiseq 2500. Bioinformatics analysis was performed to construct osteoporosis-related competing endogenous RNA (ceRNA) networks. Gene interference and osteogenic induction were used to examine the effect of identified ceRNA networks on osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (HBMSCs). RESULTS miR-1303 was lowly expressed, while cochlin (COCH) and KCNMA1-AS1 were highly expressed in the osteoporosis subjects. COCH knockdown improved the osteogenic differentiation of HBMSCs. Meanwhile, COCH inhibition compensated for the suppression of osteogenic differentiation of HBMSCs by miR-1303 knockdown. Further, KCNMA1-AS1 knockdown promoted osteogenic differentiation of HBMSCs through downregulating COCH by sponging miR-1303. CONCLUSIONS Our findings suggest that the KCNMA1-AS1/miR-1303/COCH axis is a promising biomarker and therapeutic target for osteoporosis.

UI MeSH Term Description Entries
D010012 Osteogenesis The process of bone formation. Histogenesis of bone including ossification. Bone Formation,Ossification, Physiologic,Endochondral Ossification,Ossification,Ossification, Physiological,Osteoclastogenesis,Physiologic Ossification,Endochondral Ossifications,Ossification, Endochondral,Ossifications,Ossifications, Endochondral,Osteoclastogeneses,Physiological Ossification
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016326 Extracellular Matrix Proteins Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of extracellular matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the extracellular matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ). Extracellular Matrix Protein,Matrix Protein, Extracellular,Matrix Proteins, Extracellular,Protein, Extracellular Matrix,Proteins, Extracellular Matrix
D016372 RNA, Antisense RNA molecules which hybridize to complementary sequences in either RNA or DNA altering the function of the latter. Endogenous antisense RNAs function as regulators of gene expression by a variety of mechanisms. Synthetic antisense RNAs are used to effect the functioning of specific genes for investigative or therapeutic purposes. Antisense RNA,Anti-Sense RNA,Anti Sense RNA,RNA, Anti-Sense
D051037 Large-Conductance Calcium-Activated Potassium Channel alpha Subunits The pore-forming subunits of large-conductance calcium-activated potassium channels. They form tetramers in CELL MEMBRANES. Large-Conductance Calcium-Activated Potassium Channels, alpha Subunit,MaxiK Channel alpha Subunit,Large Conductance Calcium Activated Potassium Channel alpha Subunits,Large Conductance Calcium Activated Potassium Channels, alpha Subunit
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Yuan Lin, and Hanhao Dai, and Guoyu Yu, and Chao Song, and Jun Liu, and Jie Xu
June 2022, Experimental cell research,
Yuan Lin, and Hanhao Dai, and Guoyu Yu, and Chao Song, and Jun Liu, and Jie Xu
January 2022, International journal of medical sciences,
Yuan Lin, and Hanhao Dai, and Guoyu Yu, and Chao Song, and Jun Liu, and Jie Xu
November 2023, Life sciences,
Yuan Lin, and Hanhao Dai, and Guoyu Yu, and Chao Song, and Jun Liu, and Jie Xu
January 2022, Human cell,
Yuan Lin, and Hanhao Dai, and Guoyu Yu, and Chao Song, and Jun Liu, and Jie Xu
January 2020, European review for medical and pharmacological sciences,
Yuan Lin, and Hanhao Dai, and Guoyu Yu, and Chao Song, and Jun Liu, and Jie Xu
April 2024, Journal of cellular physiology,
Yuan Lin, and Hanhao Dai, and Guoyu Yu, and Chao Song, and Jun Liu, and Jie Xu
December 2020, Molecular and cellular biochemistry,
Yuan Lin, and Hanhao Dai, and Guoyu Yu, and Chao Song, and Jun Liu, and Jie Xu
April 2024, Cell biology international,
Yuan Lin, and Hanhao Dai, and Guoyu Yu, and Chao Song, and Jun Liu, and Jie Xu
February 2021, Journal of natural products,
Yuan Lin, and Hanhao Dai, and Guoyu Yu, and Chao Song, and Jun Liu, and Jie Xu
February 2016, Biochemical and biophysical research communications,
Copied contents to your clipboard!